Loading…

Effect of a Previous History of Antiretroviral Treatment on Clinical Picture of Patients with Co-infection of SARS-CoV-2 and HIV: A Preliminary Study

•Compared with SARS-CoV-2 infected general population, patients with HIV co-infection mostly have milder clinical presentation.•A single test of viral RNA test and antibodies against SARS-CoV-2 might be insufficient to exclude COVID-19 infection in patients with HIV.•The milder extent of inflammator...

Full description

Saved in:
Bibliographic Details
Published in:International journal of infectious diseases 2020-11, Vol.100, p.141-148
Main Authors: Liu, Jia, Zeng, Wenjuan, Cao, Yukun, Cui, Yue, Li, Yumin, Yao, Sheng, Alwalid, Osamah, Yang, Fan, Fan, Yanqing, Shi, Heshui
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c521t-7ef7ffa8e90aa88f74adccba1ad856492656f295443e632933839f337c9b93223
cites cdi_FETCH-LOGICAL-c521t-7ef7ffa8e90aa88f74adccba1ad856492656f295443e632933839f337c9b93223
container_end_page 148
container_issue
container_start_page 141
container_title International journal of infectious diseases
container_volume 100
creator Liu, Jia
Zeng, Wenjuan
Cao, Yukun
Cui, Yue
Li, Yumin
Yao, Sheng
Alwalid, Osamah
Yang, Fan
Fan, Yanqing
Shi, Heshui
description •Compared with SARS-CoV-2 infected general population, patients with HIV co-infection mostly have milder clinical presentation.•A single test of viral RNA test and antibodies against SARS-CoV-2 might be insufficient to exclude COVID-19 infection in patients with HIV.•The milder extent of inflammatory response to SARS-CoV-2 infection might be associated with a previous history of ART in HIV-infected patients. We aimed to explore the effect of antiretroviral treatment (ART) history on clinical characteristics of patients with co-infection of SARS-CoV-2 and HIV. We retrospectively reviewed 20 patients with laboratory-confirmed co-infection of SARS-CoV-2 and HIV in a designated hospital. Patients were divided into medicine group (n = 12) and non-medicine group (n = 8) according to previous ART history before SARS-CoV-2 infection. The median age was 46.5 years and 15 (75%) were female. Ten patients had initial negative RT-PCR on admission, 5 of which had normal CT appearance and 4 were asymptomatic. Lymphocytes were low in 9 patients (45%), CD4 cell count and CD4/CD8 were low in all patients. The predominant CT features in 19 patients were multiple (42%) ground-glass opacities (58%) and consolidations (32%). Erythrocyte sedimentation rate (ESR) in the medicine group was significantly lower than that in the non-medicine group [median (interquartile range, IQR):14.0 (10.0–34.0) vs. 51.0 (35.8–62.0), P = 0.005]. Nineteen patients (95%) were discharged with a median hospital stay of 30 days (IQR, 26–30). Most patients with SARS-CoV-2 and HIV co-infection exhibited mild to moderate symptoms. The milder extent of inflammatory response to SARS-CoV-2 infection might be associated with a previous history of ART in HIV-infected patients.
doi_str_mv 10.1016/j.ijid.2020.08.045
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_a14e36db28c54e9a94650bd1887c916b</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1201971220306743</els_id><doaj_id>oai_doaj_org_article_a14e36db28c54e9a94650bd1887c916b</doaj_id><sourcerecordid>2436867224</sourcerecordid><originalsourceid>FETCH-LOGICAL-c521t-7ef7ffa8e90aa88f74adccba1ad856492656f295443e632933839f337c9b93223</originalsourceid><addsrcrecordid>eNp9Uk1vEzEQXSEQLYE_wAH5yGWDv9ZrI4QURYVGqkRESq-W12u3jjbrYjup-kP4v8ySUtELJ1szb94bvXlV9ZbgOcFEfNjOwzb0c4opnmM5x7x5Vp0S2cqaNYQ8hz_FpFYtoSfVq5y3GGMuhHxZnTAqqcINOa1-nXnvbEHRI4PWyR1C3Gd0HnKJ6X6qLsYSkispHkIyA7pMzpSdG2FiRMshjMFCdR1s2Sc34demBGhndBfKDVrGOoyTQAA4dDeL75t6Ga9qiszYo_PV1Ue0mHSHsAujAclN2ff3r6sX3gzZvXl4Z9WPL2eXy_P64tvX1XJxUduGklK3zrfeG-kUNkZK33LTW9sZYnrZCK6oaISnquGcOcGoYkwy5RlrreoUo5TNqtWRt49mq29T2MEKOpqg_xRiutYmlWAHpw3hjom-o9I23CmjuGhw1xMpgY2IDrg-H7lu993O9RZMAMOekD7tjOFGX8eDbjlTkhEgeP9AkOLPvctF70K2bhjM6OAomnImpGgpvLOKHqE2xZyT848yBOspG3qrp2zoKRsaSw3ZgKF3_y74OPI3DAD4dAQ4sPwQXNLZwi2t6yEBtoAn4X_8vwEMlcuB</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2436867224</pqid></control><display><type>article</type><title>Effect of a Previous History of Antiretroviral Treatment on Clinical Picture of Patients with Co-infection of SARS-CoV-2 and HIV: A Preliminary Study</title><source>BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS</source><source>ScienceDirect Journals</source><creator>Liu, Jia ; Zeng, Wenjuan ; Cao, Yukun ; Cui, Yue ; Li, Yumin ; Yao, Sheng ; Alwalid, Osamah ; Yang, Fan ; Fan, Yanqing ; Shi, Heshui</creator><creatorcontrib>Liu, Jia ; Zeng, Wenjuan ; Cao, Yukun ; Cui, Yue ; Li, Yumin ; Yao, Sheng ; Alwalid, Osamah ; Yang, Fan ; Fan, Yanqing ; Shi, Heshui</creatorcontrib><description>•Compared with SARS-CoV-2 infected general population, patients with HIV co-infection mostly have milder clinical presentation.•A single test of viral RNA test and antibodies against SARS-CoV-2 might be insufficient to exclude COVID-19 infection in patients with HIV.•The milder extent of inflammatory response to SARS-CoV-2 infection might be associated with a previous history of ART in HIV-infected patients. We aimed to explore the effect of antiretroviral treatment (ART) history on clinical characteristics of patients with co-infection of SARS-CoV-2 and HIV. We retrospectively reviewed 20 patients with laboratory-confirmed co-infection of SARS-CoV-2 and HIV in a designated hospital. Patients were divided into medicine group (n = 12) and non-medicine group (n = 8) according to previous ART history before SARS-CoV-2 infection. The median age was 46.5 years and 15 (75%) were female. Ten patients had initial negative RT-PCR on admission, 5 of which had normal CT appearance and 4 were asymptomatic. Lymphocytes were low in 9 patients (45%), CD4 cell count and CD4/CD8 were low in all patients. The predominant CT features in 19 patients were multiple (42%) ground-glass opacities (58%) and consolidations (32%). Erythrocyte sedimentation rate (ESR) in the medicine group was significantly lower than that in the non-medicine group [median (interquartile range, IQR):14.0 (10.0–34.0) vs. 51.0 (35.8–62.0), P = 0.005]. Nineteen patients (95%) were discharged with a median hospital stay of 30 days (IQR, 26–30). Most patients with SARS-CoV-2 and HIV co-infection exhibited mild to moderate symptoms. The milder extent of inflammatory response to SARS-CoV-2 infection might be associated with a previous history of ART in HIV-infected patients.</description><identifier>ISSN: 1201-9712</identifier><identifier>EISSN: 1878-3511</identifier><identifier>DOI: 10.1016/j.ijid.2020.08.045</identifier><identifier>PMID: 32829051</identifier><language>eng</language><publisher>Canada: Elsevier Ltd</publisher><subject>Adult ; Anti-Retroviral Agents - therapeutic use ; Antiretroviral therapy ; Betacoronavirus ; Characteristics ; Coinfection - complications ; Coinfection - drug therapy ; Coronavirus disease 2019 ; Coronavirus Infections - complications ; COVID-19 ; Female ; HIV ; HIV Infections - drug therapy ; Humans ; Length of Stay ; Male ; Middle Aged ; Pandemics ; Pneumonia, Viral - complications ; Retrospective Studies ; Reverse transcription-polymerase chain reaction ; SARS-CoV-2 ; Serum antibodies</subject><ispartof>International journal of infectious diseases, 2020-11, Vol.100, p.141-148</ispartof><rights>2020 The Author(s)</rights><rights>Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.</rights><rights>2020 The Author(s) 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c521t-7ef7ffa8e90aa88f74adccba1ad856492656f295443e632933839f337c9b93223</citedby><cites>FETCH-LOGICAL-c521t-7ef7ffa8e90aa88f74adccba1ad856492656f295443e632933839f337c9b93223</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1201971220306743$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,3549,27924,27925,45780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32829051$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liu, Jia</creatorcontrib><creatorcontrib>Zeng, Wenjuan</creatorcontrib><creatorcontrib>Cao, Yukun</creatorcontrib><creatorcontrib>Cui, Yue</creatorcontrib><creatorcontrib>Li, Yumin</creatorcontrib><creatorcontrib>Yao, Sheng</creatorcontrib><creatorcontrib>Alwalid, Osamah</creatorcontrib><creatorcontrib>Yang, Fan</creatorcontrib><creatorcontrib>Fan, Yanqing</creatorcontrib><creatorcontrib>Shi, Heshui</creatorcontrib><title>Effect of a Previous History of Antiretroviral Treatment on Clinical Picture of Patients with Co-infection of SARS-CoV-2 and HIV: A Preliminary Study</title><title>International journal of infectious diseases</title><addtitle>Int J Infect Dis</addtitle><description>•Compared with SARS-CoV-2 infected general population, patients with HIV co-infection mostly have milder clinical presentation.•A single test of viral RNA test and antibodies against SARS-CoV-2 might be insufficient to exclude COVID-19 infection in patients with HIV.•The milder extent of inflammatory response to SARS-CoV-2 infection might be associated with a previous history of ART in HIV-infected patients. We aimed to explore the effect of antiretroviral treatment (ART) history on clinical characteristics of patients with co-infection of SARS-CoV-2 and HIV. We retrospectively reviewed 20 patients with laboratory-confirmed co-infection of SARS-CoV-2 and HIV in a designated hospital. Patients were divided into medicine group (n = 12) and non-medicine group (n = 8) according to previous ART history before SARS-CoV-2 infection. The median age was 46.5 years and 15 (75%) were female. Ten patients had initial negative RT-PCR on admission, 5 of which had normal CT appearance and 4 were asymptomatic. Lymphocytes were low in 9 patients (45%), CD4 cell count and CD4/CD8 were low in all patients. The predominant CT features in 19 patients were multiple (42%) ground-glass opacities (58%) and consolidations (32%). Erythrocyte sedimentation rate (ESR) in the medicine group was significantly lower than that in the non-medicine group [median (interquartile range, IQR):14.0 (10.0–34.0) vs. 51.0 (35.8–62.0), P = 0.005]. Nineteen patients (95%) were discharged with a median hospital stay of 30 days (IQR, 26–30). Most patients with SARS-CoV-2 and HIV co-infection exhibited mild to moderate symptoms. The milder extent of inflammatory response to SARS-CoV-2 infection might be associated with a previous history of ART in HIV-infected patients.</description><subject>Adult</subject><subject>Anti-Retroviral Agents - therapeutic use</subject><subject>Antiretroviral therapy</subject><subject>Betacoronavirus</subject><subject>Characteristics</subject><subject>Coinfection - complications</subject><subject>Coinfection - drug therapy</subject><subject>Coronavirus disease 2019</subject><subject>Coronavirus Infections - complications</subject><subject>COVID-19</subject><subject>Female</subject><subject>HIV</subject><subject>HIV Infections - drug therapy</subject><subject>Humans</subject><subject>Length of Stay</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Pandemics</subject><subject>Pneumonia, Viral - complications</subject><subject>Retrospective Studies</subject><subject>Reverse transcription-polymerase chain reaction</subject><subject>SARS-CoV-2</subject><subject>Serum antibodies</subject><issn>1201-9712</issn><issn>1878-3511</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp9Uk1vEzEQXSEQLYE_wAH5yGWDv9ZrI4QURYVGqkRESq-W12u3jjbrYjup-kP4v8ySUtELJ1szb94bvXlV9ZbgOcFEfNjOwzb0c4opnmM5x7x5Vp0S2cqaNYQ8hz_FpFYtoSfVq5y3GGMuhHxZnTAqqcINOa1-nXnvbEHRI4PWyR1C3Gd0HnKJ6X6qLsYSkispHkIyA7pMzpSdG2FiRMshjMFCdR1s2Sc34demBGhndBfKDVrGOoyTQAA4dDeL75t6Ga9qiszYo_PV1Ue0mHSHsAujAclN2ff3r6sX3gzZvXl4Z9WPL2eXy_P64tvX1XJxUduGklK3zrfeG-kUNkZK33LTW9sZYnrZCK6oaISnquGcOcGoYkwy5RlrreoUo5TNqtWRt49mq29T2MEKOpqg_xRiutYmlWAHpw3hjom-o9I23CmjuGhw1xMpgY2IDrg-H7lu993O9RZMAMOekD7tjOFGX8eDbjlTkhEgeP9AkOLPvctF70K2bhjM6OAomnImpGgpvLOKHqE2xZyT848yBOspG3qrp2zoKRsaSw3ZgKF3_y74OPI3DAD4dAQ4sPwQXNLZwi2t6yEBtoAn4X_8vwEMlcuB</recordid><startdate>20201101</startdate><enddate>20201101</enddate><creator>Liu, Jia</creator><creator>Zeng, Wenjuan</creator><creator>Cao, Yukun</creator><creator>Cui, Yue</creator><creator>Li, Yumin</creator><creator>Yao, Sheng</creator><creator>Alwalid, Osamah</creator><creator>Yang, Fan</creator><creator>Fan, Yanqing</creator><creator>Shi, Heshui</creator><general>Elsevier Ltd</general><general>The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20201101</creationdate><title>Effect of a Previous History of Antiretroviral Treatment on Clinical Picture of Patients with Co-infection of SARS-CoV-2 and HIV: A Preliminary Study</title><author>Liu, Jia ; Zeng, Wenjuan ; Cao, Yukun ; Cui, Yue ; Li, Yumin ; Yao, Sheng ; Alwalid, Osamah ; Yang, Fan ; Fan, Yanqing ; Shi, Heshui</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c521t-7ef7ffa8e90aa88f74adccba1ad856492656f295443e632933839f337c9b93223</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adult</topic><topic>Anti-Retroviral Agents - therapeutic use</topic><topic>Antiretroviral therapy</topic><topic>Betacoronavirus</topic><topic>Characteristics</topic><topic>Coinfection - complications</topic><topic>Coinfection - drug therapy</topic><topic>Coronavirus disease 2019</topic><topic>Coronavirus Infections - complications</topic><topic>COVID-19</topic><topic>Female</topic><topic>HIV</topic><topic>HIV Infections - drug therapy</topic><topic>Humans</topic><topic>Length of Stay</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Pandemics</topic><topic>Pneumonia, Viral - complications</topic><topic>Retrospective Studies</topic><topic>Reverse transcription-polymerase chain reaction</topic><topic>SARS-CoV-2</topic><topic>Serum antibodies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liu, Jia</creatorcontrib><creatorcontrib>Zeng, Wenjuan</creatorcontrib><creatorcontrib>Cao, Yukun</creatorcontrib><creatorcontrib>Cui, Yue</creatorcontrib><creatorcontrib>Li, Yumin</creatorcontrib><creatorcontrib>Yao, Sheng</creatorcontrib><creatorcontrib>Alwalid, Osamah</creatorcontrib><creatorcontrib>Yang, Fan</creatorcontrib><creatorcontrib>Fan, Yanqing</creatorcontrib><creatorcontrib>Shi, Heshui</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>International journal of infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liu, Jia</au><au>Zeng, Wenjuan</au><au>Cao, Yukun</au><au>Cui, Yue</au><au>Li, Yumin</au><au>Yao, Sheng</au><au>Alwalid, Osamah</au><au>Yang, Fan</au><au>Fan, Yanqing</au><au>Shi, Heshui</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of a Previous History of Antiretroviral Treatment on Clinical Picture of Patients with Co-infection of SARS-CoV-2 and HIV: A Preliminary Study</atitle><jtitle>International journal of infectious diseases</jtitle><addtitle>Int J Infect Dis</addtitle><date>2020-11-01</date><risdate>2020</risdate><volume>100</volume><spage>141</spage><epage>148</epage><pages>141-148</pages><issn>1201-9712</issn><eissn>1878-3511</eissn><abstract>•Compared with SARS-CoV-2 infected general population, patients with HIV co-infection mostly have milder clinical presentation.•A single test of viral RNA test and antibodies against SARS-CoV-2 might be insufficient to exclude COVID-19 infection in patients with HIV.•The milder extent of inflammatory response to SARS-CoV-2 infection might be associated with a previous history of ART in HIV-infected patients. We aimed to explore the effect of antiretroviral treatment (ART) history on clinical characteristics of patients with co-infection of SARS-CoV-2 and HIV. We retrospectively reviewed 20 patients with laboratory-confirmed co-infection of SARS-CoV-2 and HIV in a designated hospital. Patients were divided into medicine group (n = 12) and non-medicine group (n = 8) according to previous ART history before SARS-CoV-2 infection. The median age was 46.5 years and 15 (75%) were female. Ten patients had initial negative RT-PCR on admission, 5 of which had normal CT appearance and 4 were asymptomatic. Lymphocytes were low in 9 patients (45%), CD4 cell count and CD4/CD8 were low in all patients. The predominant CT features in 19 patients were multiple (42%) ground-glass opacities (58%) and consolidations (32%). Erythrocyte sedimentation rate (ESR) in the medicine group was significantly lower than that in the non-medicine group [median (interquartile range, IQR):14.0 (10.0–34.0) vs. 51.0 (35.8–62.0), P = 0.005]. Nineteen patients (95%) were discharged with a median hospital stay of 30 days (IQR, 26–30). Most patients with SARS-CoV-2 and HIV co-infection exhibited mild to moderate symptoms. The milder extent of inflammatory response to SARS-CoV-2 infection might be associated with a previous history of ART in HIV-infected patients.</abstract><cop>Canada</cop><pub>Elsevier Ltd</pub><pmid>32829051</pmid><doi>10.1016/j.ijid.2020.08.045</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1201-9712
ispartof International journal of infectious diseases, 2020-11, Vol.100, p.141-148
issn 1201-9712
1878-3511
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_a14e36db28c54e9a94650bd1887c916b
source BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS; ScienceDirect Journals
subjects Adult
Anti-Retroviral Agents - therapeutic use
Antiretroviral therapy
Betacoronavirus
Characteristics
Coinfection - complications
Coinfection - drug therapy
Coronavirus disease 2019
Coronavirus Infections - complications
COVID-19
Female
HIV
HIV Infections - drug therapy
Humans
Length of Stay
Male
Middle Aged
Pandemics
Pneumonia, Viral - complications
Retrospective Studies
Reverse transcription-polymerase chain reaction
SARS-CoV-2
Serum antibodies
title Effect of a Previous History of Antiretroviral Treatment on Clinical Picture of Patients with Co-infection of SARS-CoV-2 and HIV: A Preliminary Study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T12%3A35%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20a%20Previous%20History%20of%20Antiretroviral%20Treatment%20on%20Clinical%20Picture%20of%20Patients%20with%20Co-infection%20of%20SARS-CoV-2%20and%20HIV:%20A%20Preliminary%20Study&rft.jtitle=International%20journal%20of%20infectious%20diseases&rft.au=Liu,%20Jia&rft.date=2020-11-01&rft.volume=100&rft.spage=141&rft.epage=148&rft.pages=141-148&rft.issn=1201-9712&rft.eissn=1878-3511&rft_id=info:doi/10.1016/j.ijid.2020.08.045&rft_dat=%3Cproquest_doaj_%3E2436867224%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c521t-7ef7ffa8e90aa88f74adccba1ad856492656f295443e632933839f337c9b93223%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2436867224&rft_id=info:pmid/32829051&rfr_iscdi=true